Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. XAIR
stocks logo

XAIR

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q4
FY2027Q1
2.26M
+111.26%
-0.700
-76.67%
2.73M
+136.87%
-0.580
-67.78%
3.79M
+115.3%
-0.443
-71.02%
Estimates Revision
The market is revising Upward the revenue expectations for Beyond Air, Inc. (XAIR) for FY2026, with the revenue forecasts being adjusted by 2% over the past three months. During the same period, the stock price has changed by -42.08%.
Revenue Estimates for FY2026
Revise Upward
up Image
+2%
In Past 3 Month
EPS Estimates for FY2026
Revise Downward
down Image
-2.91%
In Past 3 Month
Stock Price
Go Down
down Image
-42.08%
In Past 3 Month
Wall Street analysts forecast XAIR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XAIR is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast XAIR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XAIR is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 1.280
sliders
Low
6.00
Averages
6.00
High
6.00
Current: 1.280
sliders
Low
6.00
Averages
6.00
High
6.00
Piper Sandler
Overweight
downgrade
$20 -> $5
2025-08-13
Reason
Piper Sandler
Price Target
$20 -> $5
2025-08-13
downgrade
Overweight
Reason
Piper Sandler lowered the firm's price target on Beyond Air to $5 from $20 and keeps an Overweight rating on the shares following quarterly results. The firm says that the incremental updates are modest, with management reiterating confidence in its $12M-$16M revenue guidance and referenced multiple areas that could serve as the necessary FY26 catalysts.
D. Boral Capital
Jason Kolbert
initiated
$11
2025-07-17
Reason
D. Boral Capital
Jason Kolbert
Price Target
$11
2025-07-17
initiated
Reason
D. Boral Capital analyst Jason Kolbert initiated coverage of Beyond Air with a Buy rating and $11 price target. The firm says the company's LungFit platform represents a "disruptive leap" in nitric oxide delivery. It enables on-demand generation from ambient air without the need for high-pressure gas cylinders or chemical cassettes, the analyst tells investors in a research note. Boral believes new indications represent out-year revenue drivers for Beyond Air.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Beyond Air Inc (XAIR.O) is -0.51, compared to its 5-year average forward P/E of -2.21. For a more detailed relative valuation and DCF analysis to assess Beyond Air Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.21
Current PE
-0.51
Overvalued PE
1.63
Undervalued PE
-6.06

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.14
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
2.50
Undervalued EV/EBITDA
-6.78

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
38.80
Current PS
0.00
Overvalued PS
117.20
Undervalued PS
-39.59
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

XAIR News & Events

Events Timeline

(ET)
2025-11-26
16:31:34
Beyond Air Announces CFO Doug Larson's Resignation
select
2025-11-05 (ET)
2025-11-05
08:21:10
Beyond Air secures financing agreements totaling up to $32 million
select
2025-09-08 (ET)
2025-09-08
08:04:17
NeuroNOS Receives Orphan Drug Status for BA-101 in Treating GBM
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
3.0
11-28Benzinga
Stocks to Keep an Eye on This Friday: Chagee Holdings, Tilray Brands, and 3 Others

  • Chagee Holdings Earnings Report: Chagee Holdings Ltd. is expected to report quarterly earnings of 40 cents per share on revenue of $458.31 million, with shares rising 0.4% to $14.19 in after-hours trading.

  • Tilray Brands Stock Split: Tilray Brands Inc. announced a 1-for-10 reverse stock split, resulting in a 16% drop in shares to $0.86 in after-hours trading.

  • Globus Maritime Earnings Expectations: Analysts predict Globus Maritime Ltd. will post a quarterly loss of 12 cents per share on revenue of $10.50 million, with shares increasing 1.5% to $1.36 in after-hours trading.

  • Post Holdings Share Buyback: Post Holdings Inc. has authorized a $500 million share buyback program, leading to a 1.8% increase in shares to $102.82.

[object Object]
Preview
5.0
11-27Globenewswire
Beyond Air CFO Doug Larson Resigns, Transition Until December 5, 2025
  • Executive Change: Beyond Air's Chief Financial Officer Doug Larson has resigned, with his departure effective December 5, 2025, after which Controller Duke Drewell will assume interim CFO responsibilities to ensure continuity in financial management.
  • Transition Support: Larson will serve in an advisory role until the end of 2025 to facilitate a smooth transition, ensuring operational stability while the company searches for a permanent successor.
  • Company Development: During his tenure, Larson played a crucial role in the company's transition to a commercial entity, particularly with the launch of LungFit PH and clinical research subsidiaries, highlighting his significant impact on the company's history.
  • Financial Transparency: Larson's departure is not due to any disagreements regarding financial statements or internal controls, indicating the company's commitment to transparency and stability during executive transitions.
[object Object]
Preview
5.0
11-27Newsfilter
Beyond Air CFO Doug Larson Resigns, Transition Period Until December 5, 2025
  • Executive Change: Beyond Air's CFO Doug Larson has resigned, with a transition period ending on December 5, 2025, during which Duke Drewell, the Company's Controller, will assume interim CFO responsibilities to ensure continuity in financial management.
  • Transition Support: Larson will serve in an advisory role until the end of 2025, aiding the company in a smooth transition while a search for a permanent successor is underway, ensuring that financial operations remain unaffected during this period.
  • Company Development: During his tenure, Larson was instrumental in the commercialization of LungFit PH and the establishment of clinical research subsidiaries Beyond Cancer and NeuroNOS, highlighting his significant role in the company's transformation.
  • Financial Transparency: Larson's departure is not due to disagreements regarding financial statements or internal controls, indicating the company's commitment to transparency during executive transitions, which helps maintain investor confidence.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Beyond Air Inc (XAIR) stock price today?

The current price of XAIR is 1.28 USD — it has increased 17.43 % in the last trading day.

arrow icon

What is Beyond Air Inc (XAIR)'s business?

Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.

arrow icon

What is the price predicton of XAIR Stock?

Wall Street analysts forecast XAIR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XAIR is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Beyond Air Inc (XAIR)'s revenue for the last quarter?

Beyond Air Inc revenue for the last quarter amounts to 1.82M USD, increased 127.82 % YoY.

arrow icon

What is Beyond Air Inc (XAIR)'s earnings per share (EPS) for the last quarter?

Beyond Air Inc. EPS for the last quarter amounts to -1.25 USD, decreased -77.95 % YoY.

arrow icon

What changes have occurred in the market's expectations for Beyond Air Inc (XAIR)'s fundamentals?

The market is revising Upward the revenue expectations for Beyond Air, Inc. (XAIR) for FY2026, with the revenue forecasts being adjusted by 2% over the past three months. During the same period, the stock price has changed by -42.08%.
arrow icon

How many employees does Beyond Air Inc (XAIR). have?

Beyond Air Inc (XAIR) has 61 emplpoyees as of December 05 2025.

arrow icon

What is Beyond Air Inc (XAIR) market cap?

Today XAIR has the market capitalization of 10.25M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free